REACHing Communities (REACH) Consortium (U01) Clinical Trials Optional
FDA's REACH consortium seeks applications to advance minority health equity through research, outreach, training, and mentoring via cooperative agreements.
Funder: Food and Drug Administration (FDA)
Due Dates: No current deadline (Forecasted Opportunity)
Funding Amounts: $3,000,000 total award amount per cooperative agreement (U01)
Summary: Supports a consortium to advance minority health equity through research, outreach, training, and mentoring via cooperative agreements.
Key Information: Clinical trials are optional; multiple awards expected (up to 6); open to a wide range of applicants including nonprofits, governments, academic institutions, and for-profits.
Description
The FDA Office of Minority Health and Health Equity (OMHHE) is offering the REACHing Communities (REACH) Consortium cooperative agreement (U01) funding opportunity. This initiative aims to establish a consortium of multiple awardees focused on strengthening and advancing research, outreach, and communications related to minority health and health equity. The program also emphasizes supporting the training and mentoring of diverse students, fellows, and researchers to build capacity in this critical area.
The consortium will foster collaboration among recipients to accelerate progress in addressing racial and ethnic health disparities. Clinical trials are optional under this funding opportunity, allowing flexibility depending on the research approach.
